Background factors in people living with HIV in Japan who switch to cabotegravir plus rilpivirine: A pilot study
Author:
Funder
University of Tokyo
Publisher
Elsevier BV
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference8 articles.
1. Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection;Dandachi;AIDS Care,2021
2. Cabotegravir plus rilpivirine: first approval;Markham;Drugs,2020
3. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study;Orkin;Lancet HIV,2021
4. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study;Overton;Lancet,2021
5. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients;Mitsumoto-Kaseida;J Infect Chemother,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Favorable Virological Outcome, Characteristics of Injection Site Reactions, Decrease in Renal Function Biomarkers in Asian People with HIV Receiving Long-Acting Cabotegravir Plus Rilpivirine;AIDS Research and Human Retroviruses;2024-04-01
2. Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine;AIDS Research and Therapy;2024-01-03
3. Considerations for long-acting antiretroviral therapy in older persons with HIV;AIDS;2023-11-16
4. Changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine;2023-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3